Harm HogenEsch

9k citations
180 papers · 7.6k · h-index 51

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune responses and vaccinations
    • Advanced Drug Delivery Systems

Papers in

    • Immunotherapy and Immune Responses 37
    • T-cell and B-cell Immunology 18
    • Immune Response and Inflammation 7
    • Animal health and immunology 14
    • Veterinary Medicine and Surgery 10

Harm HogenEsch

169 papers receiving 7.3k citations

Peers

Harm HogenEsch
Comparison fields: 5 of 137
  • Immunology 2.5k
  • Pharmaceutical Science 433
  • Parasitology 365
  • Small Animals 368
  • Microbiology 232
Replace Ed C. Lavelle with:
Ed C. Lavelle Ireland
Tom H. M. Ottenhoff Netherlands
Ken J. Ishii Japan
Hiroshi Kiyono Japan
William W. Agace Sweden
Ichiro Azuma Japan
Gilla Kaplan United States
Klaus M. Heeg Germany
Dennis M. Klinman United States
Arthur Μ. Krieg United States
Harm HogenEsch relative to Ed C. Lavelle Ireland Ed C. Lavelle's profile →
Citations per field
00.5×2×4×5.8×
Ed C. Lavelle · 1×
Citations per year

Countries citing papers authored by Harm HogenEsch

Since Specialization
Citations

This map shows the geographic impact of Harm HogenEsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm HogenEsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm HogenEsch more than expected).

Fields of papers citing papers by Harm HogenEsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm HogenEsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm HogenEsch. The network helps show where Harm HogenEsch may publish in the future.

Co-authors

The 25 scholars most cited alongside Harm HogenEsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harm HogenEsch Line = papers co-authored together Harm HogenEsch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013363
2 2018325
3 2002300
4 2004253
5 1994227
6 2007227
7 2007179
8 2007172
9 2014167
10
A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.
1993158
11 2005148
12 2016144
13 2018135
14 1997132
15 2009124
16 2006117
17 2007113
18 2003109
19 199998
20 200298

About Harm HogenEsch

Harm HogenEsch is a scholar working on Immunology, Small Animals, Dermatology, Microbiology and Emergency Medicine, having authored 180 papers that have together received 7.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (37 papers), Dermatology and Skin Diseases (20 papers), T-cell and B-cell Immunology (18 papers), Animal health and immunology (14 papers), Aluminum toxicity and tolerance in plants and animals (12 papers), Veterinary Medicine and Surgery (10 papers), Influenza Virus Research Studies (9 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Immunology (2.5k citations), Pharmaceutical Science (433 citations), Parasitology (365 citations), Small Animals (368 citations) and Microbiology (232 citations). Harm HogenEsch has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Stanley L. Hem, Anna Sokolovska, Derek T. O’Hagan, John P. Sundberg, Christopher B. Fox, Fangjia Lu, Suresh K. Mittal, Marion J. Gijbels, Garry L. Morefield and Yi Shi. Their work appears in journals such as Vaccine, Veterinary Immunology and Immunopathology, Veterinary Pathology, PLoS ONE and Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact